Pan-Zhou X R, Cretton-Scott E, Zhou X J, Xie M Y, Rahmani R, Schinazi R F, Duchin K, Sommadossi J P
Department of Pharmacology and Toxicology, The Liver Center, University of Alabama at Birmingham, 35294-0019, USA.
Antimicrob Agents Chemother. 1997 Nov;41(11):2502-10. doi: 10.1128/AAC.41.11.2502.
AZT-P-ddI is an antiviral heterodimer composed of one molecule of 3'-azido-3'-deoxythymidine (AZT) and one molecule of 2',3'-dideoxyinosine (ddI) linked through their 5' positions by a phosphate bond. The metabolic fate of the dimer was studied with isolated rat, monkey, and human hepatocytes and was compared with that of its component monomers AZT and ddI. Upon incubation of double-labeled [14C]AZT-P-[3H]ddI in freshly isolated rat hepatocytes in suspension at a final concentration of 10 microM, the dimer was taken up intact by cells and then rapidly cleaved to AZT, AZT monophosphate, ddI, and ddI monophosphate. AZT and ddI so formed were then subject to their respective catabolisms. High-performance liquid chromatography analyses of the extracellular medium and cell extracts revealed the presence of unchanged dimer, AZT, 3'-azido-3'-deoxy-5'-beta-D-glucopyranosylthymidine (GAZT), 3'-amino-3'-deoxythymidine (AMT), ddI, and a previously unrecognized derivative of the dideoxyribose moiety of ddI, designated ddI-M. Trace extracellular but substantial intracellular levels of the glucuronide derivative of AMT (3'-amino-3'-deoxy-5'-beta-D-glucopyranosylthymidine [GAMT]) were also detected. Moreover, the extent of the formation of AMT, GAZT, and ddI-M from the dimer was markedly lower than that with AZT and ddI alone by the hepatocytes. With hepatocytes in primary culture obtained from rat, monkey, and human, large interspecies variations in the metabolism of AZT-P-ddI were observed. While GAZT and ddI-M, metabolites of AZT and ddI, respectively, as well as AZT 5'-monophosphate (MP) and ddI-MP were detected in the extracellular media of all species, AMT and GAMT were produced only by rat and monkey hepatocytes. No such metabolites were formed by human hepatocytes. The metabolic fate of the dimer by human hepatocytes was consistent with in vivo data recently obtained from human immunodeficiency virus-infected patients.
齐多夫定 - 双脱氧肌苷(AZT - P - ddI)是一种抗病毒异二聚体,由一分子3'-叠氮基 - 3'-脱氧胸苷(AZT)和一分子2',3'-双脱氧肌苷(ddI)通过磷酸键在其5'位连接而成。利用分离的大鼠、猴和人肝细胞研究了该二聚体的代谢命运,并将其与组成单体AZT和ddI的代谢命运进行了比较。将双标记的[14C]AZT - P - [3H]ddI以终浓度10微摩尔在新鲜分离的悬浮大鼠肝细胞中孵育后,二聚体完整地被细胞摄取,然后迅速裂解为AZT、AZT单磷酸、ddI和ddI单磷酸。如此形成的AZT和ddI随后进行各自的分解代谢。对细胞外培养基和细胞提取物的高效液相色谱分析显示存在未变化的二聚体、AZT、3'-叠氮基 - 3'-脱氧 - 5'-β - D - 吡喃葡萄糖基胸苷(GAZT)、3'-氨基 - 3'-脱氧胸苷(AMT)、ddI以及一种以前未识别的ddI二脱氧核糖部分的衍生物,命名为ddI - M。还检测到细胞外微量但细胞内大量的AMT葡糖醛酸衍生物(3'-氨基 - 3'-脱氧 - 5'-β - D - 吡喃葡萄糖基胸苷[GAMT])。此外,肝细胞从二聚体形成AMT、GAZT和ddI - M的程度明显低于单独使用AZT和ddI时的程度。对于从大鼠、猴和人获得的原代培养肝细胞,观察到AZT - P - ddI代谢存在较大的种间差异。虽然在所有物种的细胞外培养基中都检测到了分别作为AZT和ddI代谢产物的GAZT和ddI - M,以及AZT 5'-单磷酸(MP)和ddI - MP,但AMT和GAMT仅由大鼠和猴肝细胞产生。人肝细胞未形成此类代谢产物。人肝细胞中二聚体的代谢命运与最近从人类免疫缺陷病毒感染患者获得的体内数据一致。